Alps Advisors Inc. Purchases New Position in OR Royalties Inc. $OR

Alps Advisors Inc. purchased a new position in shares of OR Royalties Inc. (NYSE:OR) during the third quarter, Holdings Channel reports. The firm purchased 66,105 shares of the basic materials company’s stock, valued at approximately $2,649,000.

Several other institutional investors also recently bought and sold shares of the business. Cetera Investment Advisers grew its stake in OR Royalties by 3.5% in the 2nd quarter. Cetera Investment Advisers now owns 13,147 shares of the basic materials company’s stock valued at $337,000 after acquiring an additional 440 shares during the period. Vident Advisory LLC lifted its holdings in OR Royalties by 2.0% during the second quarter. Vident Advisory LLC now owns 42,349 shares of the basic materials company’s stock valued at $1,089,000 after purchasing an additional 820 shares in the last quarter. Vanguard Personalized Indexing Management LLC lifted its holdings in OR Royalties by 9.6% during the third quarter. Vanguard Personalized Indexing Management LLC now owns 16,471 shares of the basic materials company’s stock valued at $660,000 after purchasing an additional 1,446 shares in the last quarter. Allspring Global Investments Holdings LLC grew its position in shares of OR Royalties by 0.5% in the second quarter. Allspring Global Investments Holdings LLC now owns 283,500 shares of the basic materials company’s stock valued at $7,291,000 after purchasing an additional 1,500 shares during the period. Finally, SeaBridge Investment Advisors LLC increased its stake in shares of OR Royalties by 14.0% during the third quarter. SeaBridge Investment Advisors LLC now owns 17,677 shares of the basic materials company’s stock worth $708,000 after purchasing an additional 2,177 shares in the last quarter. 68.52% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently weighed in on OR. Raymond James Financial raised shares of OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 price target on the stock in a research note on Thursday, November 6th. Canaccord Genuity Group upgraded OR Royalties from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, October 22nd. Wall Street Zen raised OR Royalties from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 19th. Jefferies Financial Group reaffirmed a “hold” rating and set a $38.00 target price on shares of OR Royalties in a research note on Sunday, December 7th. Finally, Zacks Research upgraded shares of OR Royalties from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 4th. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $38.25.

OR Royalties Trading Up 2.0%

OR Royalties stock opened at $42.98 on Wednesday. The company has a 50-day moving average price of $38.74 and a 200 day moving average price of $35.50. OR Royalties Inc. has a 12-month low of $17.55 and a 12-month high of $47.75. The stock has a market cap of $8.04 billion, a P/E ratio of 54.41 and a beta of 0.76.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.